Phase-2 human trial of vaccine begins
Print Edition
Chinese researchers have started a second phase human trial of a possible coronavirus vaccine, the Institute of Medical Biology at Chinese Academy of Medical Sciences said yesterday, in efforts to further assess effectiveness and safety.
On Saturday, IMBCAMS began a phase-2 human test for its experimental shot, following an on-going phase-1 study that has recruited about 200 participants since May, the institute said yesterday.
According to a report by the Science and Technology Daily, the volunteers aged between 18 and 59 received the vaccine in West China Second University Hospital in Sichuan Province. The study was randomized, double-blind and placebo-controlled.
The phase-2 trials conducted in Yunnan Province will determine the shot’s dose and continue to evaluate whether the potential vaccine can safely trigger immune responses in healthy people.
A COVID-19 vaccine manufacturing plant of the institute in Kunming, capital city of Yunnan Province, will be put into use in the second half of 2020, according to the report.
None of the vaccine trials have passed large-scale, late-stage phase 3 clinical trials , a necessary step before getting regulatory approval for sale.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
